Cancer Institute A national cancer institute
designated cancer center

Christopher H. Contag

Publication Details

  • Microscopic Delineation of Medulloblastoma Margins in a Transgenic Mouse Model Using a Topically Applied VEGFR-1 Probe TRANSLATIONAL ONCOLOGY Wang, D., Chen, Y., Leigh, S. Y., Haeberle, H., Contag, C. H., Liu, J. T. 2012; 5 (6): 408-414

    Abstract:

    The unambiguous demarcation of tumor margins is critical at the final stages in the surgical treatment of brain tumors because patient outcomes have been shown to correlate with the extent of resection. Real-time high-resolution imaging with the aid of a tumor-targeting fluorescent contrast agent has the potential to enable intraoperative differentiation of tumor versus normal tissues with accuracy approaching the current gold standard of histopathology. In this study, a monoclonal antibody targeting the vascular endothelial growth factor receptor 1 (VEGFR-1) was conjugated to fluorophores and evaluated as a tumor contrast agent in a transgenic mouse model of medulloblastoma. The probe was administered topically, and its efficacy as an imaging agent was evaluated in vitro using flow cytometry, as well as ex vivo on fixed and fresh tissues through immunohistochemistry and dual-axis confocal microscopy, respectively. Results show a preferential binding to tumor versus normal tissue, suggesting that a topically applied VEGFR-1 probe can potentially be used with real-time intraoperative optical sectioning microscopy to guide brain tumor resections.

    View details for DOI 10.1593/tlo.12277

    View details for Web of Science ID 000313359800003

    View details for PubMedID 23323155

Stanford Medicine Resources:

Footer Links: